Work

A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors

Year: 2016

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-016-2958-1

Authors: Justine Yang Bruce, Patricia M. LoRusso, Priscila H. Goncalves, Elisabeth I. Heath, Elizabeth Sadowski, David R. Shalinsky, Yanwei Zhang, Anne M. Traynor, Aurora Breazna, Alejandro D. Ricart, Michael Tortorici, Glenn Liu

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Pfizer (United States)

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, University of Wisconsin Carbone Cancer Center, National Cancer Institute

Awards: G42679306, CANCER CENTER SUPPORT GRANT, G959885641

OpenAlex ID: W2276093033

FWCI: 0.151

Cites: 36

Cited by: 6

Related to: 10